在HSV-1复制缺陷载体中的遗传突变:对其在基因治疗应用中的安全性的影响
Stefano Cattaneo1,2, Barbara Bettegazzi3,4, Selene Ingusci5
1Vita-Salute San Raffaele University, Milan, Italy.
Gene therapy
|September 28, 2025
概括
简单疹病毒1型 (HSV-1) 载体对脑基因疗法有很大的前景. 研究人员在HSV-1糖蛋白gB中发现了导致神经元中有害融合的特定突变,强调了安全查的必要性.
科学领域:
- 神经科学是一个神经科学.
- 病毒学 病毒学
- 基因治疗 基因治疗
背景情况:
- 简单疹病毒1型 (HSV-1) 是已知的口腔感染,但也在神经科学中研究.
- 由于HSV-1具有双重作用:参与神经退行以及由于其庞大的基因组而作为基因治疗载体的潜力.
- 了解HSV-1神经相互作用对于开发用于脑疾病的安全基因治疗载体至关重要.
研究的目的:
- 评估HSV-1载体批次的安全性,特别是寻找不必要的融合性活动.
- 在生产过程中识别可能赋予HSV-1载体融合性质的突变.
- 为了确保HSV-1载体在直接注射到大脑膜内时的安全性.
主要方法:
- 全基因组测序用于分析病毒批量.
- 电生理学用于评估神经元功能.
- 病毒工程比较不同的病毒构造.
主要成果:
- 确定了特定的突变,例如UL27基因中的A到I在549位,这赋予了糖蛋白gB的融合性能力.
- 证明这些突变会在转导的神经元中诱导一种过度兴奋的表型.
- 强调了这样的同胞体变异可以在生产过程中逃避负面选择.
结论:
- 在HSV-1糖蛋白gB中的某些突变可以导致有害的融合性活性和神经元过激动性.
- 在直接的中枢神经系统基因疗法中,HSV-1载体的同胞体变异构成安全风险.
- 识别和避免这些同位体变异对于神经基因治疗中安全应用HSV-1载体至关重要.
相关概念视频
Viral Mutations
39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Microorganisms in Medicine and Therapeutics
982
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
982


